The World Health Organization has added Regeneron Pharmaceuticals’ antibody drug cocktail of casirivimab and imdevimab to the list of therapies for Covid-19 patients *****tp2DO6p1sV — Pharma Tech Focus (@PharmaTechFocus) September 27, 2021
The World Health Organization has added Regeneron Pharmaceuticals’ antibody drug cocktail of casirivimab and imdevimab to the list of therapies for Covid-19 patients *****tp2DO6p1sV